Dianthus Therapeutics, Inc. /DE/ Marketable Securities (Current)
Dianthus Therapeutics, Inc. /DE/ (DNTH) had Marketable Securities (Current) of $54.41 million as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2023-03-23
- 2022-12-31: Marketable Securities, Current $54.41M.
- 2022-09-30: Marketable Securities, Current $69.26M.
- 2022-06-30: Marketable Securities, Current $84.59M.
- 2022-03-31: Marketable Securities, Current $84.84M.
| Period end | Marketable Securities, Current |
|---|---|
| 2022-12-31 | $54.41M 10-K · filed 2023-03-23 |
| 2022-09-30 | $69.26M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $84.59M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $84.84M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $45.28M 10-K · filed 2023-03-23 |
| 2021-09-30 | $35.08M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $52.77M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $83.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $90.68M 10-K · filed 2022-03-08 |
| 2020-09-30 | $20.05M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $40.21M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $55.47M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $80.66M 10-K · filed 2021-03-03 |
| 2019-09-30 | $75.06M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $139.16M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $96.07M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $84.22M 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |